Cellular Immune Response after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Hematopoietic stem cell transplant (HSCT) recipients have a high risk of developing primary varicella-zoster virus (VZV) infection and reactivation. VZV vaccination may prevent infection and reactivation. In the current study, recipients of allogeneic HSCT (34 females, 45 males) were vaccinated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Koldehoff, Michael, Horn, Peter A., Lindemann, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143460/
https://www.ncbi.nlm.nih.gov/pubmed/35632565
http://dx.doi.org/10.3390/vaccines10050809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143460/
https://www.ncbi.nlm.nih.gov/pubmed/35632565
http://dx.doi.org/10.3390/vaccines10050809

Ejemplares similares